FULL POSTER SESSION ABSTRACTScharacterized gene products using these new terms to uncharacterized orthologs in other Candida species. Through genome annotation and analysis, weidentified candidate pathogenicity genes in seven non-albicans Candida species and in one additional C. albicans strain, WO-1. We also defined a set of theC. albicans genes at the intersection of biofilm formation, filamentous growth, pathogenesis and phenotypic switching and now, finger and tentacledevelopment, of this opportunistic fungal pathogen, which provide a compelling list of candidates for further experimentation.225. Genome sequencing of Verticillium albo-atrum pathotypes in order to understand wilt disease in hop production. J. Jakse 1 , G. Rot 2 , V. Jelen 1 , S.Radisek 3 , S. Mandelc 1 , A. Majer 1 , B. Zupan 2 , B. Javornik 1 . 1) Agronomy Department, Biotechnical faculty, University of Ljubljana, Ljubljana, Slovenia; 2)Bioinformatics Laboratory, Faculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia; 3) Slovenian Institute of Hop Researchand Brewing, Zalec, Slovenia.Verticillium wilt of hop is a vascular disease caused by V. albo-atrum, outbreaks of the lethal strains of which threaten current hop production in Europe.<strong>Fungal</strong> isolates differ in aggressiveness and have been classified by pathogenicity tests into mild and lethal pathotypes. In general, the mild strain infectionvaries in intensity from year to year and rarely causes the death of the whole plant, whereas lethal strain infection causes very severe symptoms, withrapid plant withering and dieback. Lethal strains with increased virulence in hop were first reported in the UK in 1933, followed by outbreaks in Slovenia in1997 and in Germany in 2005. Sequencing the genomes of mild and lethal V. albo-atrum hop isolates aimed at the dissection of the pathotype genomes, inorder to provide an insight into their genomic structure, which might explain the increased virulence of the lethal strain, enable the detection of virulenceassociatedfactors and elucidate the pathogenicity in Verticillium spp. Genomes of three mild and three lethal strains from three different geographicregions were sequenced by Illumina technology. The reference lethal strain, with a larger genome than the mild strains, as confirmed by flow cytometry,was sequenced using three different length libraries producing a total of 76.3 M reads. From 4.8 to 11.5 M reads were obtained for the other five strains.Additionally, 38.3 M RNA-seq reads of mild and lethal strain transcriptomes were produced for annotation of the transcribed regions. Bioinformaticsanalyses included de-novo assembly of the reference genome, followed by mapping of the other genomes for comparison of mild and lethal strains todetermine specific regions of the strains. The reference genome was assembled into 715 contigs, with a total length of 33.59 Mb. Comparison of lethalversus mild strains revealed that 0.5 Mb of DNA was only present in the lethal strains. Gene prediction tools supported by RNA-seq analysis revealed 9858gene models, 91 of which were present in the lethal unique region. Analysis of repetitive DNA based on prebuilt models masked 1.53% of the assembledgenome, while de-novo identification of repeats masked 5.86% of the genome. The presented sequencing study established a new genomic resource fornon-alfalfa V. albo-atrum strains and will enable their virulence to be studied.226. Aegerolysin proteins from Aspergillus species. Nada Krasevec 1 , Kristina Sepcic 2 , Sasa Rezonja 1,2 , Nina Sluga 1,2 , Peter Macek 2 , Gregor Anderluh 1 . 1) L11Laboratory for Molecular Biology and Nanobiotechnology, National Institute of Chemistry, Ljubljana, Slovenia; 2) Department of Biology, BiotechnicalFaculty, University of Ljubljana, Slovenia.Currently, Aegerolysin family (Pfam06355) comprises over 300 proteins, mostly assigned as putative hemolysins, however, their function and biologicalrole is unknown. Some of them, i.e. aegerolysin, ostreolysin, pleurotolysin A, erylysin A from the Basidiomycota mushrooms (Agrocybe aegerita, Pleurotusostreatus and P. eryngei), and their orthologues, Asp-hemolysin from the human pathogens Aspergillus fumigatus (Eurotiales, Ascomycota) and PA0122(rahU) from Pseudomonas aeruginosa (Proteobacteria), have been characterized as lipid- or membrane-binding proteins. Aegerlysins are specificallydistributed among certain fungal species belonging to both Ascomycota and Basidiomycota taxa, however, they could be also found in bacteria and plants.In 2004, it was reported that in addition to the aegerolysin component A (pleurotolysin A, PlyA), a 59 kDa component B (pleurotolysin B, PlyB) is obligatoryfor the observed hemolytic activity of these proteins. In contrast to aegerolysins (component A), that appear widely distributed among differentorganisms, initial bioinformatical search of component B homologues results in a much lower number of similar putative proteins, even more, bothcomponents combined could be found in a few of fungal species only. Joint Genome Institute (JGI) has recently sequenced eight Aspergillus species (A.tubingensis, A. brasiliensis, A. acidus, A. glaucus, A. versicolor, A. sydowii, A. wentii and A. zonatus) as a result of community sequencing proposal(CSP2011). The genome sequences are available at MycoCosm (JGI) (http://genome.jgi.doe.gov/programs/fungi/index.jsf) and at the Aspergillus GenomeDatabase (AspGD) (http://www.aspgd.org/). The task of EUFGEN (EURotiales Functional GENomics consortium, http://www.eufgen.org/) is to complementthese genome sequences to those already available for the Aspergillus species. The strains were provided by CBS-KNAW fungal biodiversity center(http://www.cbs.knaw.nl/collection/AboutCollections.aspx). Our aim is to clarify experimentally the relation between the genome context for the twocomponents and their presumed hemolytic activity.227. Assembly, Annotation, and Analysis of Multiple Mycorrhizal <strong>Fungal</strong> Genomes. Alan Kuo 1 , Igor Grigoriev 1 , Annegret Kohler 2 , Francis Martin 2 ,Mycorrhizal Genomics Initiative (MGI) Consortium. 1) <strong>Fungal</strong> Genomics <strong>Program</strong>, DOE Joint Genome Institute, 2800 Mitchell Dr., Walnut Creek, CA, 94598USA; 2) Lab of Excellence ARBRE, Department of Tree-Microbe Interactions, INRA-Nancy, 54280 Champenoux, France.Mycorrhizal fungi play critical roles in host plant health, soil community structure and chemistry, and carbon and nutrient cycling, all areas of intenseinterest to the US Dept. of Energy (DOE) Joint Genome Institute (JGI). To this end we are building on our earlier sequencing of the Laccaria bicolor genomeby partnering with INRA-Nancy and the mycorrhizal research community in the MGI to sequence and analyze dozens of mycorrhizal genomes of allBasidiomycota and Ascomycota orders and multiple ecological types (ericoid, orchid, and ectomycorrhizal). JGI has developed and deployed highthroughputsequencing techniques, and Assembly, RNASeq, and Annotation Pipelines. In 2012 alone we sequenced, assembled, and annotated 12 draft orimproved genomes of mycorrhizae, and predicted ~232831 genes and ~15011 multigene families, All of this data is publicly available on JGI MycoCosm(http://jgi.doe.gov/fungi/), which provides access to both the genome data and tools with which to analyze the data. Preliminary comparisons of thecurrent total of 14 public mycorrhizal genomes suggest that 1) short secreted proteins potentially involved in symbiosis are more enriched in some ordersthan in others amongst the mycorrhizal Agaricomycetes, 2) there are wide ranges of numbers of genes involved in certain functional categories, such assignal transduction and post-translational modification, and 3) novel gene families are specific to some ecological types.228. Comparative reannotation of 21 Aspergillus genomes. Asaf A. Salamov, Robert Riley, Igor Grigoriev. DOE Joint Genome Inst, Walnut Creek, CA.We used comparative gene modeling to reannotate 21 Aspergillus genomes from MycoCosm and AspGD.Initial automatic annotation of individualgenomes may contain some errors of different nature, for example, missing genes, incorrect exon-intron structures, 'chimeras', which fuse 2 or moregenes,or splitting genes into 2 or more models.The main premise behind the comparative modeling approach is that for closely related genomes mostorthologous families have the same conserved gene structure. The algorithm maps all gene models predicted in all individual Aspergillus genomes to eachgenomes and for each locus selects among the potentially many competing models the one, which most closely resembles the orthologous genes fromother genomes. This procedure is iterated until no change in gene models will be observed. For the 21 Aspergillus genomes we predicted a total of 4503new gene models ( ~2% per genome), supported by comparative analysis, additionally correcting ~18% of oldgene models. This resulted in total of 4065176
FULL POSTER SESSION ABSTRACTSmore genes with annotated PFAM domains(~3% increase per genome). Analysis of few genomes with transcriptomics data shows that new annotation setsalso have a higher number of EST-supported splice sites at exon-intron boundaries.229. Using the phenotypic information in the PHI-base database to explore pathogen genomes, transcriptomes and proteomes. Martin Urban 1 , JohnAntoniw 2 , Natalia Martins 3 , Artem Lysenko 2 , Jacek Grzebyta 2 , Elzbieta Janowska-Sedja 2 , Mansoor Saqi 2 , Kim Hammond-Kosack 1 . 1) Plant Biology and CropScience, Rothamsted Research, Harpenden, Hertfordshire, United Kingdom; 2) Computational and Systems Biology, Rothamsted Research, Harpenden,Hertfordshire, United Kingdom; 3) Embrapa - Genetic Resources and Biotechnology, Brasília, Brazil.The Pathogen-Host Interactions database (www.phi-base.org), called PHI-base, stores expertly curated molecular and biological information on genes forwhich the effect on pathogen-host interactions has been tested experimentally. <strong>Fungal</strong>, oomycete and bacterial pathogens which infect animal, plant, fish,insect and/or fungal hosts are included. Information is also given on the target sites of some anti-infective chemistries. This database, available since 2005,is used to analyse effectively the growing number of verified genes that mediate an organism's ability to cause disease and/or to trigger host responses.PHI-base is also used as a valuable resource for the functional annotation of novel genomes (http://phytopathdb.org), in comparative genomics studiesand for the discovery of candidate targets in medically and agronomically important microbial pathogens for intervention with synthetic chemistries andnatural products (fungicides). Each curated entry in PHI-base is checked by individual species experts and is supported by strong experimental evidence(e.g. gene deletion, complementation experiments) and literature references. This extensive manual curation aims to position PHI-base as a ‘goldstandard’ for researchers in the pathogen-host biology community. Genes are annotated using controlled vocabularies (Gene Ontology terms, ECNumbers, etc.), and links to other external data sources (for example, NCBI taxonomy, EMBL and UniProt) are provided. Here we describe a significantupdate of PHI-base (Version 3.4) in which the data content has more than doubled. PHI-base now provides information on more than 2,200 genesdescribed in 3000 pathogen-host interactions, which are associated with more than 106 pathogenic species. A Fusarium species case study is presented,where the database content has been used in an integrated network analysis (combining information from gene co-expression, predicted protein-proteininteractions and sequence similarity) to predict proteins in Fusarium graminearum that may be involved in pathogenicity. This approach has identified 215candidates including 29 proteins currently annotated as ‘hypothetical’. As the content of PHI-base grows, we expect this database to be an importantresource for exploring conserved and species-specific themes in pathogenicity.230. RNA-Seq analysis reveals new gene models and alternative splicing in Fusarium graminearum. Chunzhao Zhao 1,2 , Cees Waalwijk 1 , Pierre Wit 1 ,Dingzhong Tang 2 , Theo vanderLee 1 . 1) Wageningen-UR, Wageningen, Gelderland, Netherlands; 2) 3State Key Laboratory of Plant Cell and ChromosomeEngineering, Institute of <strong>Genetics</strong> and Developmental Biology, Chinese Academy of Sciences, Beijing 100101, China.The genome of Fusarium graminearum has been sequenced and annotated, but correct gene annotation remains a challenge. In addition,posttranscriptional regulations, such as alternative splicing and RNA editing, are poorly understood in F. graminearum. Here we took advantage of RNA-Seq to improve gene annotations and to identify alternative splicing and RNA editing in F. graminearum. In total 25,720,650 reads were generated fromRNA-Seq. Transcripts were detected for 84% of the genes predicted by machine annotation in the BROAD database, Of these reads, 74.8% matched toexonic regions, 10.6% to untranslated regions (UTRs), 12.9% to intergenic regions and only 1.7% to intronic regions. We identified and revised 655incorrectly predicted gene models (10% of the gene models that could be tested), including revisions of intron predictions, intron splice sites andprediction of novel introns. In addition, we identified 231 genes with two or more alternative splice variants, mostly due to intron retention. In-frameanalysis showed that the majority of these alternatively spliced transcripts lead to premature termination codons, PTCs. Apart from PTC isoforms, somealternatively spliced transcripts encoding proteins with diverse lengths were identified. The effects of the diversity in the transcript length on the biologicalfunction of proteins are still unknown, but several functions including binding properties, intracellular localization, enzymatic activity or stability may beaffected. Interestingly, the expression ratios between different transcript isoforms appeared to be developmentally regulated. Surprisingly, no RNA editingwas identified in F. graminearum. Moreover, 2459 novel transcriptionally active regions (nTARs) were identified and our analysis indicates that many ofthese could be genes that were missed in the automated annotation. A number of representative novel gene models and alternatively spliced genes werevalidated by reverse transcription polymerase chain reaction and sequencing of the generated amplicons. Our results demonstrate that posttranscriptionalregulation can be studied efficiently using our developed RNA-Seq analysis pipeline and may be important in adaptation of F. graminearum to changingenvironmental conditions that occur during different growth stages.231. Comparison of transcriptome technologies in the MpkA deletion mutant of Aspergillus fumigatus. Clara Baldin 1,3 , Sebastian Mueller 2 , Marco Groth 4 ,Konrad Gruetzmann 5 , Reinhard Guthke 2 , Olaf Kniemeyer 1,3 , Axel Brakhage 1,3 , Vito Valiante 1 . 1) Department of Molecular and Applied Microbiology, LeibnizInstitute for Natural Product Research and Infection Biology, Hans-Knöll-Institute, Beutenbergstr. 11a, 07745 Jena, Germany; 2) Department of SystemsBiology / Bioinformatics, Leibniz Institute for Natural Product Research and Infection Biology, Hans-Knöll-Institute, Beutenbergstr. 11a, 07745 Jena,Germany; 3) Department of Microbiology and Molecular Biology, Friedrich Schiller University Jena, Beutenbergstrasse 11a, 07745 Jena, Germany; 4)Genome Analysis, Leibniz Institute for Age Research - Fritz Lipmann Institute, Beutenbergstr. 11, 07745 Jena, Germany; 5) Department of Bioinformatics,Friedrich Schiller University Jena, Ernst-Abbe-Platz 2, 07743 Jena, Germany.RNA deep sequencing techniques are rising as powerfull strategy to analyze the transcriptome profile of different organisms. Especially, this approachwill be very helpful whenever a microarray platform has not been established yet or when different platforms show low reproducibility of the generateddata. In the present study, the expression profile of Aspergillus fumigatus has been analysed via different transcriptome analysis approaches. A. fumigatusis a saprophytic fungus that is emerging as one of the most important airborne fungal pathogens. The adaptation of this fungus to different environmentsstimulated research on the regulation of the cell-wall integrity pathway, which is mediated by the Mitogen Activated Protein Kinase (MAPK) MpkA.Previuos microarray analyses showed that MpkA is involved not only in the regulation of genes responsible for cell wall maintenance, but also inprotection against reactive oxygen species, iron starvation response and secondary metabolites production (Jain et al., Mol. Microbiol. 2011). Using thesame strains and lab conditions, we performed a transcriptome study using RNA deep sequencing to directly compare different transcriptome analysistechniques. The RNA-seq technique was found to be more sensitive than microarray analyses giving us the possibility to gain new insight into the role ofMpkA. We were able to identify a substantial number of novel transcripts, to detect new exons, untranslated regions, thousands of new splice junctions,and found evidence for widespread alternative splicing events. We could also identify a large group of genes belonging to known and unknown geneclusters, which are normally involved in secondary metabolite production. They are differentially regulated in the DmpkA mutant strain. Moreover, thetranscriptome data were compared to proteome data. Comparison between these two biological levels contributes to a better understanding of transcriptstability and of post-transcriptional regulatory mechanisms, giving a more global overview about MpkA regulatory circuits (Müller, Baldin et al., BMC2012).<strong>27th</strong> <strong>Fungal</strong> <strong>Genetics</strong> <strong>Conference</strong> | 177
- Page 1:
Asilomar Conference GroundsMarch 12
- Page 7 and 8:
SCHEDULE OF EVENTSFriday, March 157
- Page 10 and 11:
EXHIBITSThe following companies hav
- Page 12 and 13:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 14:
CONCURRENT SESSIONS SCHEDULESWednes
- Page 17 and 18:
CONCURRENT SESSIONS SCHEDULESThursd
- Page 19:
CONCURRENT SESSIONS SCHEDULESFriday
- Page 22 and 23:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 24:
CONCURRENT SESSIONS SCHEDULESSaturd
- Page 27 and 28:
PLENARY SESSION ABSTRACTSThursday,
- Page 29 and 30:
PLENARY SESSION ABSTRACTSFriday, Ma
- Page 31 and 32:
PLENARY SESSION ABSTRACTSSaturday,
- Page 33 and 34:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 35 and 36:
CONCURRENT SESSION ABSTRACTSUnravel
- Page 37 and 38:
CONCURRENT SESSION ABSTRACTSSynergi
- Page 39 and 40:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 41 and 42:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 43 and 44:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 45 and 46:
CONCURRENT SESSION ABSTRACTSA draft
- Page 47 and 48:
CONCURRENT SESSION ABSTRACTSRegulat
- Page 49 and 50:
CONCURRENT SESSION ABSTRACTSWednesd
- Page 51 and 52:
CONCURRENT SESSION ABSTRACTSThursda
- Page 53 and 54:
CONCURRENT SESSION ABSTRACTSThursda
- Page 55 and 56:
CONCURRENT SESSION ABSTRACTSThursda
- Page 57 and 58:
CONCURRENT SESSION ABSTRACTSThursda
- Page 59 and 60:
CONCURRENT SESSION ABSTRACTSThursda
- Page 61 and 62:
CONCURRENT SESSION ABSTRACTSThe mut
- Page 63 and 64:
CONCURRENT SESSION ABSTRACTSInnate
- Page 65 and 66:
CONCURRENT SESSION ABSTRACTSThursda
- Page 67 and 68:
CONCURRENT SESSION ABSTRACTSGenome-
- Page 69 and 70:
CONCURRENT SESSION ABSTRACTSIdentif
- Page 71 and 72:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 73 and 74:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 75 and 76:
CONCURRENT SESSION ABSTRACTSThe Scl
- Page 77 and 78:
CONCURRENT SESSION ABSTRACTSThe rol
- Page 79 and 80:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 81 and 82:
CONCURRENT SESSION ABSTRACTSCompari
- Page 83 and 84:
CONCURRENT SESSION ABSTRACTSNovel t
- Page 85 and 86:
CONCURRENT SESSION ABSTRACTSFriday,
- Page 87 and 88:
CONCURRENT SESSION ABSTRACTSEffect
- Page 89 and 90:
CONCURRENT SESSION ABSTRACTSCommon
- Page 91 and 92:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 93 and 94:
CONCURRENT SESSION ABSTRACTSSeconda
- Page 95 and 96:
CONCURRENT SESSION ABSTRACTSSheddin
- Page 97 and 98:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 99 and 100:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 101 and 102:
CONCURRENT SESSION ABSTRACTSSaturda
- Page 103 and 104:
CONCURRENT SESSION ABSTRACTSprocess
- Page 105 and 106:
CONCURRENT SESSION ABSTRACTSSpecifi
- Page 107 and 108:
LISTING OF ALL POSTER ABSTRACTSBioc
- Page 109 and 110:
LISTING OF ALL POSTER ABSTRACTS81.
- Page 111 and 112:
LISTING OF ALL POSTER ABSTRACTS160.
- Page 113 and 114:
LISTING OF ALL POSTER ABSTRACTS239.
- Page 115 and 116:
LISTING OF ALL POSTER ABSTRACTS322.
- Page 117 and 118:
LISTING OF ALL POSTER ABSTRACTS401.
- Page 119 and 120:
LISTING OF ALL POSTER ABSTRACTSmedi
- Page 121 and 122:
LISTING OF ALL POSTER ABSTRACTS558.
- Page 123 and 124:
LISTING OF ALL POSTER ABSTRACTS640.
- Page 125 and 126:
LISTING OF ALL POSTER ABSTRACTS723.
- Page 127 and 128:
FULL POSTER SESSION ABSTRACTS5. Cha
- Page 129 and 130: FULL POSTER SESSION ABSTRACTS13. In
- Page 131 and 132: FULL POSTER SESSION ABSTRACTSbioche
- Page 133 and 134: FULL POSTER SESSION ABSTRACTS30. Me
- Page 135 and 136: FULL POSTER SESSION ABSTRACTS38. Me
- Page 137 and 138: FULL POSTER SESSION ABSTRACTSidenti
- Page 139 and 140: FULL POSTER SESSION ABSTRACTSsecret
- Page 141 and 142: FULL POSTER SESSION ABSTRACTSinvolv
- Page 143 and 144: FULL POSTER SESSION ABSTRACTSdiploi
- Page 145 and 146: FULL POSTER SESSION ABSTRACTSSaccha
- Page 147 and 148: FULL POSTER SESSION ABSTRACTSresist
- Page 149 and 150: FULL POSTER SESSION ABSTRACTS96. Ce
- Page 151 and 152: FULL POSTER SESSION ABSTRACTS104. M
- Page 153 and 154: FULL POSTER SESSION ABSTRACTScan ex
- Page 155 and 156: FULL POSTER SESSION ABSTRACTSturgor
- Page 157 and 158: FULL POSTER SESSION ABSTRACTSlike p
- Page 159 and 160: FULL POSTER SESSION ABSTRACTSIndoor
- Page 161 and 162: FULL POSTER SESSION ABSTRACTSlength
- Page 163 and 164: FULL POSTER SESSION ABSTRACTSA scre
- Page 165 and 166: FULL POSTER SESSION ABSTRACTSthen q
- Page 167 and 168: FULL POSTER SESSION ABSTRACTS170. S
- Page 169 and 170: FULL POSTER SESSION ABSTRACTSof sup
- Page 171 and 172: FULL POSTER SESSION ABSTRACTSis fzo
- Page 173 and 174: FULL POSTER SESSION ABSTRACTSgrowth
- Page 175 and 176: FULL POSTER SESSION ABSTRACTSSeq da
- Page 177 and 178: FULL POSTER SESSION ABSTRACTS212. T
- Page 179: FULL POSTER SESSION ABSTRACTSCompar
- Page 183 and 184: FULL POSTER SESSION ABSTRACTSmolecu
- Page 185 and 186: FULL POSTER SESSION ABSTRACTSunexpe
- Page 187 and 188: FULL POSTER SESSION ABSTRACTSrapid
- Page 189 and 190: FULL POSTER SESSION ABSTRACTS260. T
- Page 191 and 192: FULL POSTER SESSION ABSTRACTSFusari
- Page 193 and 194: FULL POSTER SESSION ABSTRACTSScienc
- Page 195 and 196: FULL POSTER SESSION ABSTRACTS286. G
- Page 197 and 198: FULL POSTER SESSION ABSTRACTSincomp
- Page 199 and 200: FULL POSTER SESSION ABSTRACTSfound
- Page 201 and 202: FULL POSTER SESSION ABSTRACTS312. I
- Page 203 and 204: FULL POSTER SESSION ABSTRACTSall th
- Page 205 and 206: FULL POSTER SESSION ABSTRACTSPia La
- Page 207 and 208: FULL POSTER SESSION ABSTRACTS335. A
- Page 209 and 210: FULL POSTER SESSION ABSTRACTS342. F
- Page 211 and 212: FULL POSTER SESSION ABSTRACTSThis i
- Page 213 and 214: FULL POSTER SESSION ABSTRACTSJacobs
- Page 215 and 216: FULL POSTER SESSION ABSTRACTScalciu
- Page 217 and 218: FULL POSTER SESSION ABSTRACTSThe ab
- Page 219 and 220: FULL POSTER SESSION ABSTRACTSexpres
- Page 221 and 222: FULL POSTER SESSION ABSTRACTS394. F
- Page 223 and 224: FULL POSTER SESSION ABSTRACTS398. U
- Page 225 and 226: FULL POSTER SESSION ABSTRACTSthe id
- Page 227 and 228: FULL POSTER SESSION ABSTRACTS415. A
- Page 229 and 230: FULL POSTER SESSION ABSTRACTSAcuM b
- Page 231 and 232:
FULL POSTER SESSION ABSTRACTSdiverg
- Page 233 and 234:
FULL POSTER SESSION ABSTRACTSBck1 f
- Page 235 and 236:
FULL POSTER SESSION ABSTRACTSin the
- Page 237 and 238:
FULL POSTER SESSION ABSTRACTS455. T
- Page 239 and 240:
FULL POSTER SESSION ABSTRACTSor hos
- Page 241 and 242:
FULL POSTER SESSION ABSTRACTSfragme
- Page 243 and 244:
FULL POSTER SESSION ABSTRACTSenhanc
- Page 245 and 246:
FULL POSTER SESSION ABSTRACTSassess
- Page 247 and 248:
FULL POSTER SESSION ABSTRACTSmating
- Page 249 and 250:
FULL POSTER SESSION ABSTRACTScommon
- Page 251 and 252:
FULL POSTER SESSION ABSTRACTSOne of
- Page 253 and 254:
FULL POSTER SESSION ABSTRACTScells
- Page 255 and 256:
FULL POSTER SESSION ABSTRACTSof Ave
- Page 257 and 258:
FULL POSTER SESSION ABSTRACTSascaro
- Page 259 and 260:
FULL POSTER SESSION ABSTRACTSis a n
- Page 261 and 262:
FULL POSTER SESSION ABSTRACTSand th
- Page 263 and 264:
FULL POSTER SESSION ABSTRACTSCiuffe
- Page 265 and 266:
FULL POSTER SESSION ABSTRACTSon oth
- Page 267 and 268:
FULL POSTER SESSION ABSTRACTScopies
- Page 269 and 270:
FULL POSTER SESSION ABSTRACTSChem.
- Page 271 and 272:
FULL POSTER SESSION ABSTRACTS593. C
- Page 273 and 274:
FULL POSTER SESSION ABSTRACTS601. P
- Page 275 and 276:
FULL POSTER SESSION ABSTRACTSE.elym
- Page 277 and 278:
FULL POSTER SESSION ABSTRACTSThe de
- Page 279 and 280:
FULL POSTER SESSION ABSTRACTSMicrob
- Page 281 and 282:
FULL POSTER SESSION ABSTRACTSchromo
- Page 283 and 284:
FULL POSTER SESSION ABSTRACTSmating
- Page 285 and 286:
FULL POSTER SESSION ABSTRACTSAt the
- Page 287 and 288:
FULL POSTER SESSION ABSTRACTSemerge
- Page 289 and 290:
FULL POSTER SESSION ABSTRACTS666. G
- Page 291 and 292:
FULL POSTER SESSION ABSTRACTSof che
- Page 293 and 294:
FULL POSTER SESSION ABSTRACTSthe lo
- Page 295 and 296:
FULL POSTER SESSION ABSTRACTSin the
- Page 297 and 298:
FULL POSTER SESSION ABSTRACTSpotent
- Page 299 and 300:
FULL POSTER SESSION ABSTRACTSpoint
- Page 301 and 302:
FULL POSTER SESSION ABSTRACTS716. p
- Page 303 and 304:
FULL POSTER SESSION ABSTRACTSnatura
- Page 305 and 306:
FULL POSTER SESSION ABSTRACTSelemen
- Page 307 and 308:
KEYWORD LISTABC proteins ..........
- Page 309 and 310:
KEYWORD LISThigh temperature growth
- Page 311 and 312:
AUTHOR LISTBolton, Melvin D. ......
- Page 313 and 314:
AUTHOR LISTFrancis, Martin ........
- Page 315 and 316:
AUTHOR LISTKawamoto, Susumu... 427,
- Page 317 and 318:
AUTHOR LISTNNadimi, Maryam ........
- Page 319 and 320:
AUTHOR LISTSenftleben, Dominik ....
- Page 321 and 322:
AUTHOR LISTYablonowski, Jacob .....
- Page 323 and 324:
LIST OF PARTICIPANTSLeslie G Beresf
- Page 325 and 326:
LIST OF PARTICIPANTSTim A DahlmannR
- Page 327 and 328:
LIST OF PARTICIPANTSIgor V Grigorie
- Page 329 and 330:
LIST OF PARTICIPANTSMasayuki KameiT
- Page 331 and 332:
LIST OF PARTICIPANTSGeorgiana MayUn
- Page 333 and 334:
LIST OF PARTICIPANTSNadia PontsINRA
- Page 335 and 336:
LIST OF PARTICIPANTSFrancis SmetUni
- Page 337 and 338:
LIST OF PARTICIPANTSAric E WiestUni